Roland Mark Fryou, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7407a Saint Bernard Hwy, Arabi, LA 70032 Phone: 504-278-7401 Fax: 504-278-7475 |
News Archive
One of the leading causes of inherited blindness in humans, retinitis pigmentosa, is analogous to retinal dystrophies that lead to blindness in dogs. Because of their similarities, identifying gene mutations underlying several types of canine retinal dystrophies has suggested courses for research on RP in humans. These advances are significant for both humans and dogs.
Preoperative statin therapy has a protective effect on patients undergoing elective abdominal aortic aneurysm repair that reduces risk and subsequent total hospital costs according to a new study from researchers at the East Carolina Heart Institute in Greenville, North Carolina.
The search to discover and validate the first-ever clinical biomarker to diagnose and treat pancreatic cancer is at the foundation of a new, cross-sector collaboration. Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological research approach; the Cancer Center at Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital, and the Pancreatic Cancer Research Team managed by Cancer Research And Biostatistics announced today they will work together to eradicate the disease.
In the current issue of Cardiovascular Innovations and Applications (Volume3, Number 1, 2018, pp. pp. 21-30(10); DOI 10.15212/CVIA.2017.0050, Ali N. Zaidi and W. Aaron Kay from Columbus Ohio Adult Congenital Heart Disease Program, The Heart Center, Nationwide Children's Hospital and Division of Cardiovascular Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH, USA and the Division of Pediatric Cardiology, The Heart Center, Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA consider how following reparative surgery for tetralogy of Fallot or critical pulmonary stenosis, patients frequently present with severe right ventricular volume overload due to pulmonary regurgitation, resulting in decreased RV function.
The National Institutes of Health has awarded Dr. Walter Fast, associate professor of medicinal chemistry at The University of Texas at Austin's College of Pharmacy, a four-year $2.1 million grant to develop small-molecules that counter antibiotic resistance in Gram-negative bacteria. If successful, the research could lead to new drugs for treating bacterial infections that are resistant to most antibiotics.
› Verified 7 days ago